Company intelligence / Profile preview

Jointechlabs

Brandon, Florida, United Statesjointechlabs.com ↗

Ownership: Private
Employees: ~7
Development stage: Commercial

Overview

The company’s flagship product, MiniTC®, has received FDA clearance and CE Mark approval. It enables point-of-care preparation of autologous microfat with demonstrated safety and effectiveness in pain management, orthopedics, aesthetics, wound healing, and more. Clinical experience supports its use with improved efficiency over traditional methods. Their first injectable biologic program for osteoarthritis has regulatory clearance as a device-based therapy.

Therapeutic areas: OtherDermatologyRheumatologyNeurology
Modalities: DeviceCell therapyBiologic
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

JTL-T-01

Pre-clinical

Indications: Osteoarthritis

1 more asset in the full pipeline.

Partnerships

Distributors signed globally per IndieBio profile, but no major pharma partnerships disclosed.

Beyond the preview

Go deeper on Jointechlabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jointechlabs.